Myriad Genetics , Inc . ( NASDAQ : MYGN ) Q4 2022 Earnings Call Transcript
Myriad Genetics, Inc. (NYSE:MYGN) has announced a quarterly earnings release for the first time in more than two decades. Here is the full transcript of the fourth quarter and full year 2022 financial earnings call.
Source: insidermonkey.comPublished on 2023-03-03
Related news
- High - resolution surface water dynamics in Earth small and medium - sized reservoirs
- Think Globally , Accelerate Locally - The Aspen Institute
- Saying Transparency Is Good Is Not Enough : It Must Be Ingrained in Your Policies , Culture and Technologies
- H Lundbeck A / S ( HLUKF ) CEO Deborah Dunsire on Q2 2022 Results - Earnings Call Transcript
- Climate change : Do we have to rethink what we eat ?
- EUIPO approves blockchain platform ; NFT trademark mystery ; SHOP SAFE Act hearing set – news digest
- Virtual Panel : How Open - Source is Helping to Change the World
- The Trade Desk ( TTD ) Q4 2021 Earnings Call Transcript
- Confounding and Confusing Events 12 / 20 / 21
- To better healthcare with open data
- Albireo Pharma , Inc . ( ALBO ) Q1 2021 Earnings Call Transcript
- Frontiers | Sick or Sad ? A Qualitative Study on How Dutch GPs Deal With Sadness Complaints Among Young Adults
- An OIX perspective on digital identities and trust
- Nonprofit Creates Tool Addressing K - 12 Mental Health Crisis
- Data providers - Valuable partners for every player in the financial industry